Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state.
Level 5 - mechanism / opinion, no new human data
Preclinical in vitro laboratory study
PubMed 22056670 · doi:10.1101/gad.173922.111
What was done
Investigators applied an optimized direct reprogramming protocol to convert senescent and centenarian human somatic cells into induced pluripotent stem cells (iPSCs). They evaluated whether cellular senescence prevented reprogramming, compared the resulting iPSCs to human embryonic stem cells (hESCs), and assessed the ability of the derived pluripotent cells to redifferentiate.
What was found
The abstract provides no quantitative metrics or numerical values. It reports that senescent and centenarian cells were successfully reprogrammed into iPSCs indistinguishable from hESCs, showing reset telomere length, gene expression profiles, oxidative stress, and mitochondrial metabolism. Furthermore, these pluripotent stem cells were reported to redifferentiate into fully rejuvenated cells.
Why it matters
The findings show that advanced donor age and cellular senescence are not insurmountable biological barriers to pluripotency reprogramming. This establishes proof-of-concept for deriving functional, patient-matched iPSCs from elderly donors for regenerative medicine applications.
Limits
This is an entirely in vitro cell-culture study; cellular reset in culture does not demonstrate tissue- or organism-level rejuvenation in vivo. The abstract reports no quantitative values, donor sample size (n), reprogramming efficiency rates, or assessments of genomic stability and oncogenic risk.
Cited by
- supports Expressing the four Yamanaka transcription factors (OSKM) can reprogram somatic cells, including skin cells from an 80-year-old human, back to an embryonic-like pluripotent stem cell state capable of forming almost all body tissues.
- supports Cellular reprogramming resets damaged mitochondria back to a younger, better-functioning state.